You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

E7389

Showing 1 - 25 of 109
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Japan (E7389-LF, Nivolumab)

Active, not recruiting
  • Solid Neoplasms
  • Nagoya, Aichi, Japan
  • +18 more
Jan 31, 2023

Solid Tumor Trial in Japan (E7389-LF)

Active, not recruiting
  • Solid Tumor
  • Kashiwa, Chiba, Japan
  • +11 more
Nov 28, 2022

Breast Inflammatory Carcinoma, Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston

Recruiting
  • Breast Inflammatory Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2022

Metastatic Malignant Tumor in the Adult Brain, Primary Brain Tumor Trial in Duarte (procedure, drug, other)

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Adult Brain
  • Primary Brain Tumor
  • Therapeutic Conventional Surgery
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Mar 16, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)

Recruiting
  • Liposarcoma
  • +5 more
  • Eribulin Mesylate
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 17, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

Completed
Has Results
  • Estrogen Receptor Negative
  • +4 more
  • Duarte, California
  • +2 more
Jun 6, 2022

Breast Cancer Trial in Houston (Paclitaxel, Eribulin, 5-Fluorouracil)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 26, 2021

Malignant Solid Tumour, Breast Cancer Nos Metastatic Recurrent, Neuropathy Trial in San Francisco (Eribulin, Cyclophosphamide)

Completed
Has Results
  • Malignant Solid Tumour
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2021

Breast Tumor Trial in United States (Eribulin Mesylate, Pembrolizumab)

Completed
Has Results
  • Breast Neoplasm
  • Duarte, California
  • +21 more
Apr 6, 2022

Metastatic Breast Cancer Trial in United States (Eribulin mesylate, Biologic: PEGylated recombinant human hyaluronidase

Terminated
Has Results
  • Metastatic Breast Cancer
  • Eribulin mesylate
  • +2 more
  • Whittier, California
  • +6 more
Jun 25, 2020

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Suspended
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Copanlisib Hydrochloride
  • Eribulin Mesylate
  • Gainesville, Florida
  • +10 more
Nov 16, 2022

Bladder Cancer Trial in Worldwide (Gemcitabine, E7389, Cisplatin)

Terminated
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +41 more
Feb 3, 2022

Efficacy in Patients With Soft Tissue Sarcomas

Completed
  • Sarcoma, Soft Tissue
  • Eribulin mesylate
  • Osaka, Japan
  • +1 more
Apr 3, 2020

Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

Recruiting
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • +20 more
  • Duarte, California
  • +16 more
Aug 10, 2022

Metastatic Breast Cancer Trial in San Francisco, Durham, Nashville (PLX3397, Eribulin)

Completed
Has Results
  • Metastatic Breast Cancer
  • San Francisco, California
  • +2 more
Jul 2, 2020

Solid Tumors Trial in United Kingdom (Eribulin-LF)

Completed
Has Results
  • Solid Tumors
  • Sutton, Surrey, United Kingdom
  • +3 more
May 20, 2019

Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin

Completed
Has Results
  • Refractory or Recurrent Solid Tumors
  • +3 more
  • Eribulin mesilate
  • Irinotecan hydrochloride
  • Marseille, Bouches-du-Rhône, France
  • +38 more
Jun 20, 2022

Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory

Suspended
  • Breast Adenocarcinoma
  • +4 more
  • Eribulin Mesylate
  • +3 more
  • Scottsdale, Arizona
  • +38 more
May 25, 2022

Recurrent Breast Carcinoma, Stage IV Breast Cancer Trial in United States (Eribulin Mesylate, Laboratory Biomarker Analysis)

Completed
Has Results
  • Recurrent Breast Carcinoma
  • Stage IV Breast Cancer
  • Eribulin Mesylate
  • Laboratory Biomarker Analysis
  • Anchorage, Alaska
  • +11 more
Jul 10, 2020

Breast Cancer Trial in United States (Eribulin Mesylate, Ixabepilone)

Completed
Has Results
  • Breast Cancer
  • Sedona, Arizona
  • +49 more
Nov 2, 2021

Resolution of Eribulin-Induced Peripheral Neuropathy

Completed
  • Locally Advanced or Metastatic Breast Cancer
  • Amberg, Germany
  • +65 more
Jul 12, 2022

Breast Cancer Trial in Worldwide (E7389, Physician's Choice)

Completed
Has Results
  • Breast Cancer
  • E7389
  • Physician's Choice
  • Birmingham, Alabama
  • +136 more
Dec 17, 2019

Metastatic Breast Cancer Trial in Worldwide (Eribulin Mesylate, Capecitabine)

Completed
Has Results
  • Metastatic Breast Cancer
  • Anaheim, California
  • +168 more
May 28, 2020

Ovarian Cancer Trial (Aribulin;carboplatin;bevacizumab)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Jul 20, 2023